committee

Members

Byoung S. Kwon

Founder & CEO

Dr. Kwon is currently operating a company called Eutilex as the CEO, which he founded in 2015. Dr. Kwon has been Distinguished Professor and Investigator at the National Cancer Center, Korea, and Professor at the Department of Medicine Tulane University, New Orleans LA since 2008. He was Professor and Director at the Immunomodulation Research Center at the University of Ulsan Korea from 1999 to 2008, and was a tenured Professor of the Indiana University School of Medicine from 1988 to 1999. Dr. Kwon was trained at the Georgia Regents University and later at the Department of Human Genetics, Yale University. He is developingImmunotherapeuticsagainst intractable diseases based upon his life-long research in the area of T cell costimulation and immunomodulation.

  Year                   Degree                   Institution and Location                                             Major

1966 -1968            Certificate             College of General Arts & Sciences                           Predentistry

                                                            Seoul National University, Seoul, Korea       

1968 - 1972           D.D.S.                   College of Dentistry                                                   Dentistry

                                                            Seoul National University, Seoul, Korea

1972 - 1974           M.S.                      Department of Microbiology                                      Microbiology

                                                            College of Medicine

                                                            Seoul National University, Seoul, Korea

1978 - 1981           Ph.D.                     Department of Cell and Molecular Biology,              Microbiology

                                                            Medical College of Georgia, Augusta, GA                Immunology

1981 - 1984           Postdoctoral          Department of Human Genetics                               Human Genetics

                              Fellow                   Yale University School of Medicine

                                                            New Haven, CT

2009 - 2009           Certificate             Graduate School of International Studies                   Global Leadership

(Mar)   (Jun)                                         Seoul National University and                                     Program (GLP)

                                                             the Korea International Trade Academy,                                             

                                                             Seoul, Korea

Dr. Kwon’s research focuses on immunotherapy against cancers and autoimmune diseases. Dr. Kwon has established a concept called “inducible costimulation” by discovering 4-1BB-4-1BBL and AITR-AITRL systems. He has proved that immune functions can be selectively suppressed or enhanced through the inducible costimulation and presented the possibility of “selective immunotherapy”. Antigen-specific T cell therapeutics that Dr. Kwon’s team has developed are in phase 1 trials against various cancers in the NCC. 

1968 - 1972                 Scholarship in honor of scholastic record from the                                                      Association of Alumni,

                                    Seoul National University

1980                            Travel award from the International Conference on Human                                       Herpes Virus   

1982 - 1983                 National Research Service Award, NIH       

1984                            Travel award from the International Lymphokine                                                        Workshop,          

                                    Schloss Elmau, West Germany

1983 - 1984                 Swebilius Cancer Research Award, Yale University            

1985 - 1987                 Feasibility Grant Program Award, American Diabetes                                                Association Inc.

1985 - 1988                 Young Investigator Research Award, NIH

2004                            Distinguished Scholar Award, Korean Research Foundation

2005                            International Cytokine Society Award, ICS2005

2005                            Star Faculty Award, Korean Research Foundation

2006                            Faculty of the Year, University of Ulsan

2006                            Innovative Research Award, American Arthritis Foundation

2010                            Award for Promotion of Cancer Research,

                                    Japan Foundation for Promotion of Cancer Research

2012                            Presidential Award, Promotion of Bio-Research and

                                    Industry,

                                    Korean Ministry of Health and Welfare

  1. Invited lecture. “A b-chemokine, MRP-1, inhibits colony formation of bone marrow myeloid progenitors.” FASEB ’95, AAI Minisymposia; chemokine: activities and regulation (co-Chair and speaker) Atlanta, GA - April 10, 1995
     
  2. Invited lecture. “T cell costimulatory receptor 4-1BB.” Human Genome Sciences, Rockville, MD-September 11, 1995
     
  3. Invited lecture. “Function and clinical application of T cell costimulatory molecules.” Bayer Corporation; Research and Development Strategic Alliance, Asilomar, CA - November 24, 1995
     
  4. Invited lecture. “Function and signaling of T cell costimulatory receptor 4-1BB.” Keystone Symposium, Hilton Head, SC - March 19, 1996
     
  5. Invited lecture. “Newly-identified members of TNFR superfamily.” SmithKline Beecham Pharmaceuticals, King of Prussia, PA - May 17, 1996
     
  6. Special lecture.  “Cell death and survival in regulation of immune responses”. The International Symposium on Bioscience and Technology, Seoul, Korea - June 17, 1996
     
  7. Organizer, chair and speaker.  Osteoclastogenesis:  genes and signals".  International Symposium on Molecular and Cellular Biology in Dentistry - Seoul National University School of Dentistry, Seoul, Korea - June 5, 1997
     
  8. Invited lecture.  “A new member of the TNFR superfamily”.  AAAAI/AAI/CIS Joint meeting, San Francisco, CA - February 20-26, 1997
     
  9. Invited lecture.  “Osteoclastogenesis:  Factors and Signaling”. Human Genome Sciences, Inc., Rockville, MD - September 5, 1997
     
  10. Organizer and chair.  International Symposium on Technology and Industry - Indiana University School of Medicine Cancer Center, Indianapolis, IN - December 6, 1997
     
  11. Invited lecture. “Inducible costimulation and immunological memory.” FASEB Summer Conference - July 22, 1998
     
  12. Organizer and Chair. Symposium on current Korean Economy, and the role of Science and Technology- Indiana University Bloomington Campus - February 21, 1998
     
  13. Plenary lecture. “Immunomodulation through T cell costimulation.” Korean Society for Biochemistry and Molecular Biology - April 30, 1999
     
  14. Invited lecture. “Chemokines and Chemokine receptors.” Korean Society for Molecular and Cell Biology - March 29, 1999
     
  15. Plenary lecture.  "4-1BB medicated immunomodulation".  Korean Society for Immunologists, March 24, 1999
     
  16. Plenary lecture. “Domain-specific functions of HIV-1 coreceptor CCR5.” 5th International AIDS Symposium, NIH, Korea - September 19, 1999
     
  17. Plenary lecture. “Functions of C6 beta-chemokines” Korean Association of Immunobiologists - June 2, 2000
     
  18. Invited lecture.  “T cell activation and Costimulation”. Symposium at Medical Science Institute of Catholic  Medical School. September 16, 2000
     
  19. Invited lecture. “Differentiation factor of turtle neural crest stem cells.” Symposium on Stem cell Biology, Korean Society for Molecular and Cellular Biology - October, 2000
     
  20. Plenary lecture.  “Osteoclastic differentiation of Mesenchymal Stem Cells” Symposium on Genetics and  Molecular Biology of Mineralized Tissues 7th KAOB International Symposium. June, 2001
     
  21. Invited lecture.  “Introduction to T cell costimulation” Korean Society for Immunology. November, 2001
     
  22. Invited lecture.  “T cell costimulation and autoimmune Herpetic Stromal Keratitis” International Symposium on “Functional Proteomics & Genomics” November 16-17, 2001
     
  23. Invited lecture.  “Osteogenic differentiation of human mesenchymal stem cell” KAOB 2001 International  symposium “Genetics and Molecular Biology of Mineralized Tissues” June 25, 2001
     
  24. Invited lecture.  “Quantitative structure-activity relationships for antitumor activity of nitroazoles: a comparative analysis for the parent compounds and their nitroanione radical and nitorsoanione radical derivatives” 5th Korea-Russia International symposium on Science and Technology. June 26-July 3, 2001
     
  25. Plenary lecture. “Immunomodulation through T-cell costimulation.” The 9th Federation Meeting of Korean Basic Medical Scientists, Seoul, Korea - April 26, 2001
     
  26. Invited lecture. “Costimulation and Induction of Immune Tolerance.” Inaugural Symposium of Organ Transplantation Research Center, SNU Medical School - January 5, 2002
     
  27. Invited lecture. “Costimulation and immune tolerance.” Tulane Regional Primate Research Center, Covington, LA; Tulane University School of Medicine - February 22, 2002
     
  28. Plenary lecture. “Cross-road between immune and skeletal systems: Players and Diseases.” The 21th Annual Meeting of the Korean Society of Endocronology, Seoul, Korea - May 1-2, 2003
     
  29. Invited lecture. “4-1BB-mediated immunotherapy.” Annual Meeting of Korean Association of Immunobiologists - May 11, 2003
     
  30. Invited lecture. “Treatment of autoimmune diseases by modulating costimulatory receptors.” Korean Society for Biochemistry and Molecular Biology - May 15, 2003
     
  31. Plenary lecture. “Regulators of Regulatory T cells.” The 6th cardiovascular genomics symposium, Seoul, Korea - December 5, 2003
     
  32. Plenary lecture. “Immunomodulation-based therapy of Cancers and Autoimmune Diseases.” Osong International Bio-conference, Osong, Korea - October 13, 2004
     
  33. Invited lecture. “T cell costimulation in immunity.” International Vaccine Institute, Seoul, Korea –Symposium on Mucosal Immunity - October 25-30, 2004
     
  34. Invited lecture. “4-1BB-mediated Immunotherapy” LSU Medical Center, New Orleans, LA - January 28, 2005
     
  35. Invited lecture. “4-1BB-targeted immunotherapy against autoimmune diseases and cancer.” FIMSA 2005, Hangzhou, China - April 21, 2005
     
  36. Plenary lecture. “Immunotherapy of autoimmune diseases and cancer.” Korean Society of Hematology, Seoul, Korea - May 27, 2005
     
  37. Invited lecture. “Korea on the Move: New Frontier in Biotechnology.” BioEurope 2005, Dresden, Germany  (Participated as the leader of Invest Korea and KOTRA group) - November 7-10, 2005
     
  38. Plenary lecture. “Immunobiology of costimulatory receptors and ligands”. Korean Society of   transplantation, Jeonju, Korea – April 8, 2006
     
  39. Invited lecture. “4-1BB-targeted Immunotherapy against autoimmune diseases and cancers.” Bristol-Myers-Squibb Company, Princeton, NJ – February 7, 2006
     
  40. Invited lecture. “Bio-Medical Science and Industry in Korea.” 3rd EU-Korea Forum, Brussels, Belgium  May 23,2006
     
  41. Invited lecture. “Costimulation and germinal center –targeted immunotherapy.” Korea-Swiss Biomedical Symposium, Seoul Korea- May 31-June 1, 2006
     
  42. Invited lecture. “Development of immunotherapeutics targeting regulatory T and germinal center.” 3rd  Korea-Swiss Biomedical Symposium, Seoul, Korea, May 31-June 1, 2006
     
  43. Plenary lecture. “Basic and clinical research of TNFR family molecules” Korea-Japan Translational Research Conference, Nagoya, Japan- October 14, 2006-12-26
     
  44. Invited lecture. “Development of immunotherapeutics targeting T cell costimulation and germinal centers.” Shanghai Immunology Society, Shanghai, China, Oct 6, 2006
     
  45. Plenary lecture. “Inducible costimulation-targeted immunotherapy against cancers and autoimmune diseases.” Biologic Asia 2006, Mumbai, India, November 28-30, 2006
     
  46. Invited lecture. “Mechanisms involved in synergistic anti-cancer effect Combination of Chemotherapy and Immunotherapy.” National Cancer Center, Korea, Jun 17, 2007
     
  47. Invited lecture. “Mechanisms involved in synergistic anti-cancer effect of combination between chemotherapeutics and anti-4-1BB.” New Frontiers in Cancer Immunotherapy, Annecy, France, Jul 9-11, 2007
     
  48. Invited lecture. “Cancer stem cells as a target for immunotherapy.” Tulane University, New Orleans LA, March 3, 2008
     
  49. Invited lecture. “Development of CTL Therapeutics.” The second international Cell Therapy Conference.” , Seoul, Korea November 20, 2008
     
  50. Invited lecture. “Cancer Stem Cells in Head and Neck Cancers.” Seoul National University, Seoul, Korea, December 12, 2008
     
  51. Invited lecture. “4-1BB(CD137)-based immunotherapy against cancers”, Chang Gung University, Taiwan, August 15,2009
     
  52. Invited lecture. “4-1BB- based Immunotherapy”, National Cancer Center, Japan, Tokyo, Japan, January 22, 2010
     
  53. Invited lecture. “Immunotherapy of autoimmune diseases”, Hamamatsu University, Hamamatsu, Japan, January 25, 2010
     
  54. Chair and Invited lecture. “4-1BB(CD137)- Mediated Immunotherapy”, International Congress of Antibodies ICA-2010, Beijing, China, March 24-26, 2010
     
  55. Invited lecture. “CTL Therapeutics”, A-IMBN Annual Conference, Taipei, Taiwan November 11-14, 2010
     
  56. Invited lecture. “4-1BB-based Adoptive Tcell Therapy”, KAI-IBS Joint conference, Korea, November 16-  19,2016
     
  57. Invited lecture. “Adoptive CAST (cancer antigen-specific T) Cell Therapy”, Cell Therapy World Asia, Korea, September 19-20, 2017
     

EDITORSHIP:

2009 – present             Infection and Drug Resistance (Editorial Board)

2009 – present             Journal of Pharmacological Research (Editorial Board)       

2008 – present             International Journal of Oncology (Editorial Academy)

2006 – 2008                Journal of Leukocyte Biology (Section Editor)

2005 – present           Cytokine (Associate Editor)

2001 – present           Cell Biology International (Editorial Board)

2011 – present           Journal of Biomedicine and Biotechnology

                                   Lead Guest Editor for “The Role of Costimulation in Cancers and

                                   Autoimmune Diseases”                                      

2017- present             Journal of Clinical Case Reports(Editorial Board)

2017- present             SM Bone Marrow Research (SMJBR)(Editorial Advisory Board)

2017- present             Clinical Cancer Drugs (Editorial Advisory Board)

2017- present             International Journal of Cancer Biology(Editorial Board)

2017- present            Journal of Immunology Forecast (Editorial Board)

2017- present            Journal of Allergy and Immunology: Annals of Medical Case Reports

                                  (Editorial Board)

PUBLICATIONS:

1. Kwon BS, Lee SH, Lee HW: Studies on a method of rapid test for hepatitis-associated antigen and its occurrence in Korea. Kor J Virol 3:38-51, 1973

2. Chang WH, Kwon BS, Shin YW, Lee SH: Studies on the distribution, infectious patterns and susceptibility to various antibiotics of bacteria isolated from purulent materials. Seoul J Med 14:41-48, 1973

3. Kwon BS: The distribution, isolate patterns and susceptibilities to antibiotics of bacteria isolated from infectious oro-dental lesion.  J Dental College SNU 2:53-59, 1977

4. Park NH, Gangarosa LP, Kwon BS, Hill JM: Iontophoretic application of adenine arabinoside monophosphate to Herpes Simplex Virus Type 1 - infected hairless mouse skin.  Antimicrob Ag Chemother 14:605-608, 1978

5. Kwon BS, Gangarosa LP, Park NH, Hull DS, Fineberg E, Wiggins C, Hill JM: Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.  Invest Ophthalmol Vis Sci 18:984-988, 1979

6. Kwon BS, Hill JM, Wiggins C, Tuggle C, Gangarosa LP: Iontophoretic application of Ara-AMP for the treatment of HSV-2 skin infections in hairless mice. J Infect Dis 140:1014, 1979

7. Kwon BS, Gangarosa LP, Burch KD, deBack J, Hill JM: Induction of ocular herpes simplex virus shedding by epinephrine iontophoresis in rabbits. Invest Ophthalmol Vis Sci 21:442-449, 1981

8. Kwon BS, Gangarosa LP, Green K, Hill JM: Kinetics of ocular herpes simplex virus shedding induced by epinephrine iontophoresis. Invest Ophthalmol Vis Sci 22:818-821, 1982

9. Hill JM, Kwon BS, Burch KD, Deback J, Whang I, Jones GT, Luke B, Harp R, Shimomura Y, Hull DS, Gangarosa LP: Acyclovir and vidarabine monophosphate: comparison of iontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis.  Am J Med. 73:300-4, 1982

10. Hill JM, Kwon BS, Shimomura Y, Colborn GL, Yahgmai F, Gangarosa LP: Herpes simplex virus recovery in neural tissue after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea. Invest Opthalmol Vis Sci 24:243-247, 1983

11. Hill JM, Wiggins CA, Kwon BS, Gentry GA, Gangarosa LP Sr: Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice. Methods Find Exp Clin Pharmacol. 6(1):17-20, 1984

12. Kwon BS, Colborn GL, Gangarosa LP, Hill JM: Antibody-dependent cellular cytotoxicity of polymorphonuclear leukocytes and mononuclear cells against HSV-1 infected primary cultures of rabbit corneal epithelium. Curr Eye Res 3:1203-1212, 1984

13. Kwon BS, Weissman SM: Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 12-0-tetradecanoyl phorbol-13-acetate. J Virol 52:1000-1004, 1984

14. Hill JM, Shimomura Y, Kwon BS, Gangarosa LP Sr: Iontophoresis of epinephrine isomers to rabbit eyes induced HSV-1 ocular shedding. Invest Opthalmol Vis Sci 26:1299-1303, 1985

15. Kim KS, Ko YK, Moon HM, Kwon BS: cDNA cloning and expression of human interferon-gamma in E. coli. Kor J Biochem 19:266-274, 1986

16.Hill JM, Shimomura T, Dudley JB, Berman E, Haruta Y, Kwon BS, Maguire LJ: Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Invest Opthalmol Vis Sci 28:585-590, 1987

17. Demangone M, Hill JM, Kwon BS: Effect of acyclovir therapy during simultaneous reactivation of latent HSV-1 in rabbits. Antiviral Res 7:237-243, 1987

18. Kwon BS, Kim GS, Prystowsky M, Lancki D, Sabath D, Pan J, Fitch F W, Weissman SM: Isolation and initial characterization of multiple species of T-lymphocyte subset-specific cDNA clones. Proc Natl Acad Sci USA 84:2896-2900, 1987

19. Kwon BS, Haq AK, Pomerantz SH, Halaban R: Isolation and sequence of a cDNA clone for human tyrosinase which maps at the mouse albino locus. Proc Natl Acad Sci USA 84:7473-7477, 1987

20. Kwon BS, Halaban R, Kim GS, Pomerantz S, Haq A: A melanocyte-specific cDNA clone whose expression is inducible by MSH and IBMX. Mol Biol Med 4:339-356, 1987

21. Kwon BS, Haq AK, Kim GS, Pomerantz SH, Halaban R: Cloning and characterization of a human tyrosinase cDNA. Prog Clin Biol Res 256:273-282, 1988

22. Halaban R, Tamura A, Moellmann G, Kuklinska E, Lerner A, Pomerantz S, Kwon BS: Tyrosinase of murine melanocytes with mutations at the c-albino locus. Proc Natl Acad Sci USA 85:7241-7245, 1988

23. Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A: bFGF as an autocrine growth factor for human melanomas. Oncogene Res 3:177-86, 1988

24. Barton D, Kwon BS, Francke U: Human tyrosinase gene, mapped to chromosome 11 long arm (q14 q21) identifies second region of homology with mouse chromosome 7. Genomics 3:17-24, 1988

25. Kwon BS, Wakulchik M, Haq AK, Halaban R, Kestler D: Sequence analysis of mouse tyrosinase cDNA. Biochem Biophys Res Commun 153:1301-1309, 1988

26. Ruppert S, Muller G, Kwon BS, Schutz G: Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. EMBO J 7:2715-2722, 1988

27. Kwon BS, Kestler D, Lee E, Wakulchik M, Young J: Isolation and sequence analysis of serine protease cDNAs from murine cytolytic T lymphocytes. J Exp Med 168:1839-1854, 1988

28. Kwon BS, Haq AK, Kim GS, Pomerantz SH, Halaban R: Cloning and characterization of a human tyrosinase cDNA. Prog Clin Biol Res 256:273-282, 1988

29. Kwon BS, Wakulchik M, Liu C-C, Persechini PM, Trapani JA, Haq AK, Kim Y, Young JD-E: The structure of the mouse lymphocyte pore-forming protein perforin. Biochem Biophys Res Commun 158:1-10, 1989

30. Kwon BS, Weissman SM: cDNA sequences of two inducible T cell genes. Proc Natl Acad Sci USA 86:1963-1967, 1989

31. Kwon BS, Halaban R, Chintamaneni C: Molecular basis of mouse Himalayan mutation. Biochem Biophys Res Commun 161:252-260, 1989

32.Kwon BS, Kestler DP, Eshhar Z, Oh K-O, Wakulchik M: Expression characteristics of two potential T cell mediator genes. Cell Immunol 121:414-422, 1989

33. Qureshi M, Yoon JW, Kwon BS: Identification and production of monoclonal antibodies against a discriminating protein molecule between B and D variants of encephalomyocarditis virus. Develop Comp Immunol 13:263-271, 1989

34. Dieter P, Kwon BS, Hohne M, Tonjes R, Haq AD, Hoffmann B: Establishment and partial characterization of SV40 virus-immortalized hepatocyte lines of normal and lethal mutant mice carrying a deletion on chromosome 7. J Cell Physiol 139:599-609, 1989

35. Kwon BS, Haq AK, Wakulchik M, Halaban R, Barton DE, Francke U, Lamoreux LM, Whitney B, Kestler D: Isolation, chromosomal mapping and expression of mouse tyrosinase gene. J Invest Dermatol 93:589-594, 1989

36. Kwon BS, Wakulchik M, Liu C-C, Pereschini PM, Traspani JA, Haq AK, Kim Y, Young JD-E: The structure of the mouse lymphocyte pore-forming protein perforin. Biochem Biophys Res Commun 158:1-10, 1989

37. Trapani JA, Kwon BS, Kozak CA, Chintamaneni C, Young JD-E, Dupont B: Genomic organization of the mouse pore-forming protein (perforin) gene and localization to chromosome 10. J Exp Med 171:545-557, 1990

38. Liu CC, Joag SV, Kwon BS, Young JD-E: Induction of perforin and serine esterases in murine cytotoxic T lymphocyte clone. J Immunol 144:1196-1201, 1990

39. Rinchik EM, Banghan JW, Hunsicker PR, Cacheiro N, Kwon BS, Jackson IJ, Russell LB: Genetic and molecular analysis of chlorambucil-induced germ-line mutations in the mouse. Proc Natl Acad Sci USA 87:1416-1420, 1990

40. Joag SV, Liu CC, Kwon BS, Clark WR, Young JD: Expression of mRNAs for pore-forming protein and two serine esterases in murine primary and cloned effector lymphocytes. J Cell Biochem 43:81-8, 1990

41. Broxmeyer HE, Sherry B, Cooper S, Oh K, Tekamp-Olson P, Kwon BS, Cerami A: Enhancing and supressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76:1110-1116, 1990

42. Yokoyama T, Silversides DW, Waymire KG, Kwon BS, Takeuchi T, Overbeek PA: Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res 18:7293-7298, 1990

43. Young JD-E, Kwon BS, Trapani JA, Liu C-C, Young LH: Lymphocyte-mediated cytolysis: role of granule mediators. Blood Cell Biochemistry 3:143-162, 1990

44. Croy BA, Reed N, Malaskenko B-A, Kim K-K, Kwon BS: Demonstration of YAC target cells lysis by murine granulated material gland cells. Cell Immunol 133:116-126, 1991

45. Colman M-A, Shibahara S, Kwon BS, Jenkins T, Ramsay M: The b locus probes, MT4 and the human b protein cDNA, recognize the same two allele XbaI RFLP in humans. Nucleic Acids Res 19:960, 1991

46. Youn BS, Liu CC, Kim K-K, Young JD-E, Kwon MH, Kwon BS: Structure of the mouse pore forming protein (perforin) gene: Analysis of transcription initiation site; 5' flanking sequence, alternative splicing of 5' untranslated regions. J Exp Med 173:813-822, 1991

47. Chintamaneni C, Halban R, Kobayashi Y, Witkop C, Kwon BS: A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosine-negative oculocutaneous albinism. Proc Natl Acad Sci USA 88:5272-5276, 1991

48. Chintamaneni C, Ramsay M, Colman MS, Fox MF, Pickard RT, Kwon BS: Mapping the human CAS2 gene, the homologue of the mouse brown (b) locus, to human chromosome 9P22-pter. Biochem Biophys Res Commun 178:227-235, 1991

49. Bajpai A, Kwon BS, Brahmi Z: Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets. Immunology 74:258-264, 1991

50. Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A: Macrophage inflammatory protein (MIP)-1b abrogates the capacity of MIP-1a to suppress myeloid progenitor cell growth. J Immunol 147:2586-2594, 1991

51. Oh KO, Zhou Z, Kim K-K, Samanta M, Fraser M, Kim YJ, Broxmeyer HE, Kwon BS: Identification of cell surface receptors for murine macrophage inflammatory protein-1beta. J Immunol 147:2978-29831, 1991

52. Kwon BS, Chintamaneni C, Kozak CA, Copeland NG, Gilbert DJ, Jenkins N, Barton D, Francke U, Kobayashi Y, Kim K-K: A melanocyte-specific gene, pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci USA 88:9228-9232, 1991

53. Klebig ML, Kwon BS, Rinchik EM: Physical analysis of murine albino deletions that disrupt liver-specific gene regulation or mesoderm development. Mamm Genome 2:51-63, 1992

54. Maze R, Sherry B, Kwon BS, Cerami A, Broxmeyer HE: Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J Immunol 149:1004-1009, 1992

55. Lu L, Zhou Z, Wu B, Xiao M, Shen R-N, Williams DE, Kim Y-J, Kwon BS, Ruscetti S, Broxmeyer HE: Influence of recombinant human interleukin (IL)-7 on disease progression in mice infected with friend virus complex. Int J Cancer 52:261-265, 1992

56. Miyazawa K, Hendrie P, Kim Y-J, Mantel C, Yang Y-C, Kwon BS, Broxmeyer HE: Recombinant human IL-9 induces protein tyrosine phosphorylation and synergizes with steel factor to stimulate proliferation of the human factor dependent cell line, M07e. Blood 80:1685-1692, 1992

57. Ponnazhagan S, Kwon BS: A cis-acting element involved in mouse tyrosinase gene expression and partial purification of its binding protein. Pigment Cell Res 5:155-161, 1992

58. Park KC, Chintamaneni C, Halaban R, Witkop CJ, Kwon BS: Molecular analyses of a tyrosinase-negative albino family. Am J Human Genet 52:406-413, 1993

59. Colman MA, Stevens G, Ramsay M, Kwon BS, Jenkins T: Exclusion of two candidate pigment loci, c and b, a chromosomal region, part of 11p, 33 random polymorphic markers as the locus for tyrosinase-positive oculocutaneous albinism. Human Genet 90:556-560, 1993

60. Pollok KE, Kim Y-J, Zhou Z, Hurtado J, Kim K-K, Pickard RT, Kwon BS: The inducible T cell antigen 4-1BB: analysis of expression and function. J Immunol 150:771-891, 1993

61. Mantel C, Kim Y-J, Cooper S, Kwon BS, Broxmeyer HE: Polymerization of murine macrophage inflammatory protein-1alpha inactivates its myelosuppressive effects in vitro. The active form is monomer. Proc Natl Acad Sci USA 90:2232-2236, 1993

62. Rinchik EM, Stoye JP, Frankel WN, Coffin J, Kwon BS, Russell LB: Molecular analysis of viable spontaneous and radiation-induced albino (c)-locus mutations in the mouse. Mutat Res 286(2):199-207, 1993

63. Kim Y-J, Zhou Z, Pollok KE, Shaw A, Bolen J, Fraser M, Kwon BS: A T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck. J Immunol 151:1255-1262, 1993

64. Kim Y-J, Zhou Z, Hurtado J, Wood DL, Pescovitz MD, Warfel KA, Vandagriff J, Davis JK, Kwon BS: IDDM patients' sera recognize a novel 30 kD pancreatic autoantigen related to chymotrypsinogen. Immunol Invest 22:219-227, 1993

65. Kim K-K, Blakely A, Zhou Z, Park H, Clark W, Kwon BS: Changes in the level of perforin and its transcript during effector and target interactions. Immunol Lett 36:161-170, 1993

66. Zhou Z, Kim Y-J, Pollok KE, Hurtado J, Lee J-K, Broxmeyer HE, Kwon BS: Macrophage inflammatory protein-1a rapidly modulates its receptors and inhibits the aCD3-mediated proliferation of T lymphocytes. J Immunol 151:4333-4341, 1993

67. Koizumi M, Youn BS, Horta F, Fu KC, Young J, Kwon BS, Liu CC: Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins. Mol Cell Biol 13:6690-6701, 1993

68. Kwon BS: Pigmentation genes; tyrosinase gene family and Pmel 17 gene family. J Invest Dermatol 100:134S-140S, 1993

69. Pollok KE, Hurtado J, Kim Y-J, Zhou Z, Kim K-K, Kwon BS: The T cell 4-1BB antigen binds to mature B cells and macrophages, costimulates anti-mu-primed splenic B cells. Eur J Immunol 24:367-374, 1994

70. Kwon BS, Kozak CA, Kim K-K, Pickard RT: Genomic organization and chromosomal localization of the T-cell antigen 4-1BB. J Immunol 152:2256-2262, 1994

71. Foreman ME, Lamoreux ML, Kwon BS, Womack JE: Mapping the bovine albino locus. J Hered 85:318-320, 1994

72. Ponnazhagan S, Hou L, Kwon BS: Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region. J Invest Dermatol 102:744-748, 1994

73. Zhou Z, Pollok KE, Kim KK, Kim Y-J, Kwon BS: Functional analysis of T cell antigen 4-1BB in activated intestinal intraepithelial T lymphocytes. Immunol Lett 41:177-184, 1994

74. Kobayashi T, Urahe K, Orlow S, Higashi K, Imokawa G, Kwon BS, Potter F, Bearing V: The Pmel 17/Silver locus protein: characterization and investigation of its melanogenic function. J Biol Chem 269:29198-29205, 1994

75. Kwon BS, Kim K-K, Halaban R, Pickard RT: Characterization of mouse Pmel 17 gene and silver locus. Pigment Cell Res 7:394-397, 1994

76. Park KC, Kim KH, Lee YS, Kwon BS: Single-strand conformation polymorphism analysis of point mutation in a tyrosinase-negative oculocutaneous albinism. J Inherite Metabolic Dis 17:123-126, 1994

77. Kwon BS, Ponnazhagan S, Kim K-K, Chintamaneni CD, Halaban R, Bennett D, Rinchik E, Pickard RT: Mouse silver mutation is caused by a single base insertion in the putative cytoplasmic domain of Pmel 17 gene. Nucleic Acids Res 23:154-158, 1995

78. Pollok KE, Kim SH, Kwon BS: Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4. Eur J Immunol 25:488-94, 1995

79. DeBenedette M, Chu N, Pollok K, Hurtado J, Wade W, Kwon BS, Watts T: Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 181:985-992, 1995

80. Zhou Z, Kim Y-J, Kim S-H, Pollok KE, Kwon BS: Characterization of human homologues of 4-1BB and its ligand. Immunol Lett 45:67-73, 1995

81. Hou L, Kwon BS: Turtle lung cells produce a melanogenesis-stimulating activity that promotes melanocytic differentiation of avian neural crest cells. Pigment Cell Res 8:113-119, 1995

82. Youn BS, Jang IK, Broxmeyer HE, Cooper S, Jenkins NA, Gilbert DJ, Copeland NG, Elick TA, Fraser MJ, Kwon BS: A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors. J Immunol 155:2661-2667, 1995

83. Hurtado JC, Kim S-H, Pollok KE, Lee ZH, Kwon BS: Potential role of 4-1BB in T cell activation: Comparison with the costimulatory molecule CD28. J Immunol 155:3360-3367, 1995

84. Broxmeyer HE, Cooper S, Zhi HL, Li L, Ho-Yeong S, Kwon BS, Warren RE, Donner DB: Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. Int J Hematol 13:203-215, 1995

85. Chakraborty AK, Platt JT, Kim KK, Kwon BS, Bennett DC, Pawelek JM: Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pmel 17/silver locus protein.  Eur J Biochem 236:180-8, 1996

86. Lee ZH, Hou L, Moellmann G, Kuklinska E, Antol K, Fraser M, Halaban R, Kwon BS: Characterization and subcellular localization of human Pmel 17, a 100 kD premelanosomal membrane protein associated with 5,6,-dihydroxyindol-2-carboxylic acid (DHICA) converting activity. J Invest Dermatol 106:605-610, 1996

87. Garni-Wagner BA, Lee ZH, Kim Y-J, Wilde III CE, Kang CY, Kwon BS: 4-1BB is expressed on CD45RAhi CD45ROhi transitional T cell in humans. Cell Immunol 169:91-98, 1996

88. Kim K-K, Heng HHQ, Shi XM, Tsui LD, Lee ZH, Youn B-S, Pickard RT, Kwon BS: Genomic organization and FISH mapping of human Pmel 17, the putative silver locus. Pigment Cell Res 9:42-48, 1996

89. Youn BS, Kim K-K, Kwon BS: A critical role of Sp1- and Ets-related transcription factors in maintaining cytotoxic T lymphocytes-specific expression of the mouse perforin gene. J Immunol 157:3499-3509, 1996

90. Hurtado JC, Kim Y-J, Kwon BS: Signals through 4-1BB are costimulatory to previously-activated splenic T cells and inhibit activation-induced cell death. J Immunol 158:2600-2609, 1997

91. Youn B-S, Kim SH, Lyu MS, Kozak C, Taub P, Kwon BS: Molecular cloning and characterization of CHEMR1, a novel chemokine receptor which has a striking homology to the human MIP-1alpha, RANTES, MCP-1 receptor, C-C CKR-4. Blood 89:4448-4460, 1997

92. Kwon BS, Tan KB, Oh KO, Lee ZH, Kim K-K, Kim MH, Ni J, Gentz R, Yu GL, Harrop J, Lyn SD, Silverman C, Porter TG, Truneh A, Young PR: A newly-identified member of tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272:14272-14276, 1997

93. Youn B-S, Zhang SM, Lee EK, Park DH, Broxmeyer HE, Murphy PM, Locati M, Pease JE, Kim KK, Antol K, Kwon BS: Molecular cloning of leukotactin-1: a novel member of beta-chemokine, a chemoattractant for neutrophils, monocytes and lymphocytes, a potent agonist at CC chemokine receptors 1 and 3. J Immunol (Cutting Edge) 159:5201-5205, 1997

94. Jang I-K, Lee ZH, Kim Y-J, Kim SH, Kwon BS: Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kB (NFkB). Biochem Biophys Res Commun 242:613-620, 1998

95. Rosemblat S, Sviderskaya EV, Easty DJ, Wilson A, Kwon BS, Bennett DC, Orlow SJ: Melanosomal defects in melanocytes from mice lacking expression of the pink-eyed dilution gene: Correction by culture in the presence of excess tyrosine. Exp Cell Res 239:344-352, 1998

96. Wang S, Kim Y-J, Bick C, Kim SH, Kwon BS: The potential roles of 4-1BB costimulation in HIV-1 infection. AIDS Res Hum Retroviruses 14:223-231, 1998

97. Kim Y-J, Kim SH, Mantel P, Kwon BS: Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses. Eur J Immunol 28:881-890, 1998

98. Youn BS, Zhang SM, Broxmeyer HE, Cooper S, Antol K, Fraser M, Kwon BS: Characterization of CKbeta8 and CKbeta8-1: two alternatively spliced forms of human beta-chemokine, chemoattractants for neutrophils, monocytes and lymphocytes, potent agonists at CC chemokine receptor 1. Blood 91:3118-3126, 1998

99. Youn BS, Zhang SM, Broxmeyer HE, Antol K, Fraser MJ, Hangoc G, Kwon BS: Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine, with myelosuppressive activity. Biophys Biochem Res Commun 247:217-222, 1998

100. Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, Kim KK, Oh K-O, Greene J, Li Y, Su J, Gentz R, Aggarwal BB, Ni J: TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J 12:845-854, 1998

101. Zhai Y, Guo R, Hsu T-L, Yu G-L, Ni J, Kwon BS, Jiang G, Tan J, Lu J, Augustus M, Carter K, Rohas L, Endress G, Xing L, Wang S, Oh K-O, Gentz R, Lippman ME, Garotta G, Hsieh S-L, Yang D: LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102:1142-1151, 1998

102. Dass V, Kwon BS: Role of 4-1BB in immune responses. Semin Immunol 10:481-489, 1998

103. Kwon B, Yu K-Y, Ni J, Yu G-L, Jang I-K, Kim Y-J, Xing L, Liu D, Wang S-X, Kwon BS: Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem 274:6056-6061, 1999

104. Kim HH, Lu DE, Shin JN, Lu YS, Jeon YM, Ni J, Kwon BS, Lee ZH: Receptor activator of NFkappaB recruits multiple TRAF family adaptors and activates C-Jun N-terminal kinase. FEBS Lett 443:297-302, 1999

105. Vinay DS, Kwon BS: Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8+ Tc1 and Tc2 cells. Cell Immunol 192:63-71, 1999

106. Zhang SM, Youn BS, Gao JL, Murphy P, Kwon BS: Differential effects of leukotactin-1 and macrophage inflammatory protein-1alpha on neutrophils mediated by CCR1. J Immunol 162:4938-4942, 1999

107. Kwon B, Youn B-S, Kwon BS: Functions of newly-identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Curr Opin Immunol 11:340-345, 1999

108. Kim Y-J, Mantel, June CH, Kim, SH, Kwon BS: 4-1BB costimulation promotes human T cell adhesion to fibronectin. Cell Immunol 192:13-23, 1999

109. Yu K-Y, Ni J, Kwon B, Kwon BS: A newly-identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT (HVEM-L)-mediated apoptosis. J Biol Chem 274:13733-13736, 1999

110. Vinay DS, Kwon BS: Cytokine-induced Th1 and Th2 cell populations reveal differential expression of T cell activating antigen 4-1BB (CDw137) but not CD28 and exhibit variations in co-stimulatory requirements. Immunobiol 200:419-428, 1999

111. Kwon B, Kwon BS: Molecules of the tumor necrosis factor (TNF) receptor and ligand superfamilies: endless stories. J Biochem Mol Biol 32:419-428, 1999

112. Vinay DS, Kwon BS: Relative Abilities of 4-1BB(CD137) and CD28 to Co-Stimulate the Response of Cytokine Deflected Th1 and Th2 Cells. Immunobiol 200:246-263, 1999

113. Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon BS, Murphy W, Taylor PA: Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J Immunol 165:4902-4909, 2000

114.Gramaglia I, Cooper D, Miner KT, Kwon BS, Croft M: Costimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur J Immunol 30:392-402, 2000

115. Kwon B, Moon CH, Kang SW, Seo SK, Kwon BS: 4-1BB: Still in the midst of darkness.  Mol Cells 10:119-126, 2000

116. Zheng XD, Silverman B, Zhou A, Goto T, Kwon BS, Kaufman HE, Hill JM: Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest Ophthalmol Vis Sci 42:120-126, 2001

117. Youn B-S, Yu K-Y, Hui Y, Alkhatib G, Kwon BS: The seventh transmembrane domain of CC chemokine receptor 5 (CCR5) is critical for MIP-1beta binding and receptor activation. Biochem Biophys Res Commun 281:627-633, 2001

118. Blazar BR, Kwon BS, Panoskaltsis-Mortari A, Kack KB, Peschon JJ, Taylor PA: Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia (GVL) and graft rejection in allogeneic bone marrow transplant (BMT) recipients. J Immunol 166:3174-3183, 2001

119.Kim SH, Lee WH, Kwon BS, Oh GT, Choi YH, Park JE: Tumor Necrosis Factor Receptor Superfamily 12 may Destabilize Atherosclerotic Plaques by Inducing Matrix Metalloproteinases. Jpn Circ J 65:136-138, 2001

120. Choi YN, Woo KM, Ko SH, Lee YJ, Park SJ, Kim HM, Kwon BS: Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells. Eur J Immunol 31:2179-2188, 2001

121. Igor AS, Kiran KR, Kwon BS: Macrophagal Polykaryocytes in Inflammation, Tumor Growth and Tissue Remodeling. J Microbiol Biotechnol 11:727-738, 2001

122. Hill JM, Lukiw WJ, Gebhardt BM, Higaki S, Loutsch JM, Myles ME, Thompson HW, Kwon BS, Bazan NG, Kaufman HE: Gene expression analyzed by Microarrays in HSV-1 Latent Mouse Trigeminal Ganglion following Heat Stress. Virus Genes 23:273-280, 2001

123. Lee WH,  Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JH: Tumor Necrosis Factor receptor superfamily 14(TNFRSF) is involved is the athrogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21:2004-2010, 2001

124. Kondabagil KR and Kwon BS: Proteomics and Microarrays in Cancer Research. J Microbiol Biotechnol 11:907-914, 2001

125. Seo SK, Bryan MG, Lim HY, Kang SW, Higaki S, Varnell ED, Hill JM, Kaufman HE, Kwon BS: Murine keratocytes function as antigen-presenting cells. Eur J Immunol 31:3318-3328, 2001

126. Lim HY, Kim KK, Zhou FC, Yoon JW, Hill JM, Kwon BS: 4-1BB-like molecule is expressed in islet-infiltrating mononuclear cells and in the gray matter of the brain. Cell Biol Int 26:271- 8, 2002

127. Youn BS, Lim CL, Shin MK, James MH and Kwon BS: An Intronic silencer of the mouse perforin gene. Mol Cells 13:61-68, 2002

128. Jung CR, Kiran KR, Kwon BS: Mesenchymal stem cells and Osteogenesis. Immune Network 1:179-186, 2002

129. Jang IK, Lee ZH, Kim HH, Kwon BS: A novel Leucine-rich repeat protein(LRR-1): Potential  involvement in 4-1BB-mediated signal transduction. Mol Cells 12:304-312, 2001

130. Lee WH, Kim SH, Jeong EM, Choi YH, Kim DI, Lee BB, Cho YS, Kwon BS, Park JE: A novel chemokine, Leukotactin-1, induces chemotaxis, pro-atherogenic cytokines, tissue factor expression in atherosclerosis. Atherosclerosis 161:255-260, 2002

131. Kwon BS, Hurtado JC, Lee ZH, Kwack KB, Seo SK, Choi BK, Koller BH, Wolisi G, Broxmeyer HE, Vinay DS: Immune responses in 4-1BB(CD137)-deficient mice. J Immunol 168:5483-5490, 2002

132. Lee JK, Lee EH, Yun YP, Kim K, Kwack K. Na DS, Kwon BS, Lee CK: Truncation of NH2-terminal amino acid residues increases agonistic potency of leukotactin-1 on CC chemokine receptor 1 and 3. J Biol Chem 277:14757-14763, 2002

133. Yu R, Park JS, Kawada T, Kwon BS: Alteration of a macrophages inflammatory protein-related protein-2(MRP-2) response by high fat and cholesterol diet in mice. Life Sci 70:2535-2545, 2002

134. Kwon B, Lee HW, Kwon BS: New insights into the role of 4-1BB in immune responses: beyond CD8(+) T cells. Trends Immunol 23: 378-380, 2002

135. Khlebnikov A, Schepetkin I, Kwon BS: Modeling of the anticancer action for radical derivatives of nitroazoles: quantitative structure-activity relationship(QSAR) study. Cancer Biother Radiopharm 17: 193-203, 2002

136. Shin HH, Lee MH, Kim SG, Lee YH, Kwon BS, Choi HS: Recombinant glucocorticoid induced tumor necrosis factor receptor(rGITR) induces NOS in murine macrophage. FEBS Lett 514: 275-280, 2002

137. Lee H-W, Park S-J, Choi BK, Kim HH, Nam K-O, Kwon BS: 4-1BB promotes the survival of CD8+ T Lymphocytes by increasing expression of Bcl-XL and Bfl-1. J Immunol 169: 4882-4888, 2002

138. Lee U-H, Kwack KB, Park JW, Kwon BS: Molecular cloning of agonistic and antagonistic monoclonal antibodies against human 4-1BB. Eur J Immunogenet 29:449-452, 2002

139. Shin HH, Kwon BS, Choi HS: Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induced COX-2 activity in murine macrophage Raw 264.7 cells. Cytokine 19:187-192, 2002

140. La S, Kim J, Kwon BS, Kwon B: Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation. Mol Cells 14:398-403, 2002

141. Jung C-R, Schepetkin IA, Woo SB, Khlebnikov AI, Kwon BS: The osteoclastic differentiation of mesenchymal stem cells by mumie extract. Drug Develop Res 57:122-133, 2002

142. Wolisi G, Srirangam A, Vinay DS, Choi BK, Suh H-S, Suh JH, Kwon BS: Alloimmune and skin allograft responses in 4-1BB(CD137)-deficient mice. Immune Network 2:133-136, 2002                                                                                              

143. Schepetkin I, Khlebnikov A, Kwon BS: Medical Drugs From Humus Matter: Focus on Mumie. Drug Develop Res 57:140-159, 2002

144. Kim J, La S, Kim BS, Kwon BS, Kwon B: Newly identified [correction of dentified] members of the TNF receptor superfamily (mTNFRH1 and mTNFRH2) inhibit T-cell proliferation. Exp Mol Med 35:54-59, 2003

145. Shin HH, Kim SG, Lee MH, Suh JH, Kwon BS, Choi HS: Soluble glucocorticoid-induced TNF receptor (sGITR) induces inflammation in mice. Exp Mol Med. 35:358-364, 2003

146. Ra JS, Kim MW, Han I-S, Choi SW, Broxmeyer HE, Kwon BS: Osteoprotegerin inhibits differentiation of hematopoietic stem/progenitor cells. J Hematother Stem Cell Res 12:33-38, 2003

147. Kang SW, Seo SK, Hill JM, Kwon B, Lee HW, Cho HR, Vinay DS, Kwon BS: Changes in gene expression in latent HSV-1-infected rabbit trigeminal ganglia following epinephrine iontophoresis. Curr Eye Res 26:225-229, 2003

148. Vinay DS, Wolisi GO, Yu K-Y, Choi BK, Kwon BS: Immunity in the absence of CD28 and CD137 (4-1BB) molecules. Immunol Cell Biol 81:176-184, 2003

149. Kim WY, Broxmeyer HE, Han I-S, Park DH, Lee K-M, Vinay DS, Kwon BS: Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics. J Hematother Stem Cell Res 12:107-113, 2003

150. Kwon B, Kim BS, Cho HR, Park JE, Kwon BS: Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members is the pathogenesis: the HVEM-LIGHT system. Exp Mol Med 35:8-16, 2003

151. Han I-S, Ra J-S, Kim M-W, Park S-K, Kwon BS: Differentiation of CD34+ cells from human cord blood and murine bone marrow is suppressed by C6-chemokines. Mol Cells 15:176-180, 2003

152. Seo SK, Park HY, Choi JH, Kim WY, Jung HW, Kwon B, Kwon BS: Blocking 4-1BB/4-1BBL interactions prevents herpetic stromal keratitis. J Immunol 171:576-583, 2003

153. Lee HS, Shin HH, Kwon BS, Choi HS: Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage. J Cell Biochem 88:1048-1056, 2003

154. Lee HW, Nam KO, Park SJ, Kwon BS: 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D2 and E and cyclin-dependent kinase(cdk) inhibitor p27kip1. Eur J Immunol 33:2133-2141, 2003

155. Kim CS, Kawada Teruo, Yoo H, Kwon BS, Yu RN: Macrophage inflammatory protein-related protein-2, a novel CC chemokine, can regulate preadipocyte migration and adipocyte differentiation. FEBS Letters 548:125-130, 2003

156. Schepetkin IA, Khlebnikov AI, Shin YA, Jeong CS, Klubachuk ON, Kwon BS: Characterization of humic substances from mumie. J Agricul Food Chem 51:5245-5254, 2003

157. Lee HW, Nam KO, Seo SK, Kim YH, Kang H, Kwon BS: 4-1BB cross-linking enhances the survival and cell cycle progression of CD4 T lymphocytes. Cell Immunol 223:143-150, 2003

158. Kim JD, Choi BK, Bae JS, Lee UH, Han IS, Lee HW, Youn BS, Vinay D., Kwon BS: Cloning and characterization of GITR ligand. Genes Immun 4:564-569, 2003

159. Jung HW, La SJ, Kim JY, Heo SK, Kim JY, Sa Wang, Kim KK, Lee KM, Cho HR, Lee HW, Kwon Byungsuk, Kim BS, Kwon BS: High levels of soluble HVEM in sera of patients with allergic and autoimmune diseases. Exp Mol Med 35:501-508, 2003

160. Choi BK, Bae JS, Choi EM, Kang WJ, Sakaguchi Shimon, Vinay D, Kwon BS: 4-1BB-dependent inhibition of immune suppression by activated CD4+CD25+ T cells. J Leuk Biol 75:785-791, 2004

161. Jung HW, Choi SW, Choi JI, Kwon BS: Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp Mol Med 36:13-22, 2004

162. Yu R, Kim CS, Kawada T, Kwon TW, Lim TW, Kim YW, Kwon BS: Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Atherosclerosis 174:35-42, 2004

163. Lee UH, Son JH, Lee JJ, Kwon B, Park JW, Kwon BS: Humanization of Antagonistic Anti-Human 4-1BB Monoclonal Antibody Using a Phage-Displayed Combinatorial Library. J Immunother 27:201-210, 2004

164. Son JH, Lee UW, Lee JJ, Kwon B, Kwon BS, Park JW: Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library. J Immunol Methods 286:187-201, 2004

165. Kim SH, Kang YJ, Kim WJ, Woo DK, Lee Y, Kim DI, Park YB, Kwon BS, Park JE, Lee WH: TWEAK Can Induce Pro-Inflammatory Cytokines and Matrix Metalloproteinase-9 in Macrophages. Circ J 68:396-399, 2004

166. Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS: Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Transpl Int 17:351-361, 2004

167. Youn BS, Min SS, Park KS, Lee HW, Yu RN, Kwon BS: The Role of Adipocytokines in Adipocyte-Related Pathological Processes. Drug News Perspect 17:293-298, 2004

168. Hwang J, Kim CW, Son KN, Han KY, Lee KH, Kleinman HK, Ko J, Na DS, Kwon BS, Gho YS, Kim J: Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett 570:47-51, 2004

169. Vinay DS, Choi BK, Bae JS, Kim WY, Gebhardt BM, Kwon BS: CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, Have Lower IL-4 Responses. J Immunol 173:4218-4229, 2004.

170. Jung HW, Jung C-R, Choi BK, Vinay DS, Hill JM, Gebhardt BM, Kwon BS: Herpesvirus infection of ICAM-1 deficient mice. Curr Eye Res 29:201-208, 2004

171. Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, Suh JH, Choi BK, Vinay DS, Kwon BS: 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nature Med 10:1088-1094, 2004

172. Lee SM, Shin H, Jang SW, Shim JJ, Song I, Son KN, Hwang J, Shin YH, Kim HH, Lee CK, Ko J, Na DS, Kwon BS, Kim J: PLP2/A4 interacts with CCR1 and stimulates migration of CCR1-expressing HOS cells. Biochem Biophys Res Commun 324:768-772, 2004

173. Kim J, Choi WS, La S, Suh JH, Kim BS, Cho HR, Kwon BS, Kwon B: Stimulation  with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. Blood 105:2206-2213, 2005

174. Nam KO, Kang H, Shin SM, Choi KH, Kwon B, Kwon BS, Kim SJ, Lee HW: Cross-linking of 4-1BB activates TCR signaling pathways in CD8+T lymphocytes. J. Immunol 174:1898-1905, 2005

175. Kang YJ, Kim WJ, Bae HU, Kim DI, Park YB, Park JE, Kwon BS, Lee WH: Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 29:229-235, 2005

176. Kim JK, Choi EM, Shin HI, Kim CH, Hwang SH, Kim SM and Kwon BS: Characterization of monoclonal antibody specific to the Z39Ig protein, a member of immunoglobulin superfamily. Immunol Lett 99:153-161, 2005

177. Lee JK, Kim HS, Im SA, Kim K, Kwon BS, Lee CK: Identification of NH(2)-terminal amino acid residues essential for the biological activity of leukotactin-1. Immunol Lett 99:63-68, 2005

178. Lee SW, Vella AT, Kwon BS, Croft M: Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB. J Immunol 174:6803-6808, 2005

179. Hwang J, Son KN, Kim CW, Ko J, Na DS, Kwon BS, Gho YS, Kim J: Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine 30:254-263, 2005

180. Myers L, Croft M, Kwon BS, Mittler RS, Vella AT: Peptide-specific CD8 T regulatory cells use IFN-{gamma} to elaborate TGF-{beta}-based suppression. J Immunol 174:7625-7632, 2005

181. Lee SC, Ju SA, Pack HN, Heo SK, Suh JH, Park SM, Choi BK, Kwon BS, Kim BS: 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection. Infect Immun  73:5144-5151, 2005

182. Ju SA, Lee SC, Kwon TH, Heo SK, Park SM, Paek HN, Suh JH, Cho HR, Kwon B, Kwon BS, Kim BS: Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes. Immunol Cell Biol 83:344-351, 2005

183. Nam KO, Kang WJ, Kwon BS, Kim SJ, Lee HW: The therapeutic potential of 4-1BB (CD137) in cancer. Curr Cancer Drug Targets 5:357-363, 2005

184. Noh EK, Ra JS, Lee SA, Kwon BS, Han IS: CKb8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34+ cells. Exp mol med 37:619-623, 2005

185. Nishimoto H, Lee SW, Hong H, Potter KG, Maeda-Yamamoto M, Kinoshita T, Kawakami Y, Mittler RS, Kwon BS, Ware CF, Croft M, Kawakami T: Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106:4241-4248, 2005

186. Kim YH, Seo SK, Choi BK, Kang WJ, Kim CH, Leu SK, Kwon BS: 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CDllc+CD8+ T cells. Cell Immunol 238:76-86, 2006

187. Shin YH, Son KN, Lee GW, Kwon BS, Kim J: Transcriptional regulation of human CC chemokine CCL15 gene by NF-KB and AP-1 elements in PMA-stimulated U937 monocytoid cells. Biochim Biophys acta 1732:38-42, 2005

188. Marten P, Kwon BS, Shen C, Hertogh GD, Cadot P, Bullens DMA, Overbergh L, Mathieu C, Assche GV, Geboes K, Rutgeerts P, Ceuppens JL: Involvement of 4-1BB (CD137)-4-1BB ligand interaction in the modulation of CD4+ T cell-mediated inflammatory colitis. Clin Exp Immunol 143:228-236, 2006

189. Myers L, Lee SW, Rossi RJ, Lefrancois L, Kwon BS, Mittler RS, Croft M, Vella A: Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells. Int Immunol 18:325-333, 2006

190. Vinay DS, Kwon BS: Immunotherapy targeting 4-1BB and its ligand. Int J Hematol 83:23-28, 2006

191. Son KN, Kwon BS, Kim J: Human CC chemokine CCL23 enhances invasion and matrix metalloproteinase 2 expression in vascular endothelial cells. Biochem Biophys Res Commun 340:498-504, 2006

192. Shin HH, Lee EA, Kim SJ, Kwon BS, Choi HS: A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-kappaB ligand (RANKL)-induced osclastogenesis by increasing IFN-beta production. FEBS Lett 580:1601-1606, 2006

193. Heo SK, Ju SA, Lee SC, Park SM, Choe SY, Kwon B, Kwon BS, Kim BS: LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM. J Leukoc Biol 79:330-338, 2006

194. Byun JS, Kim DU, Ahn BC, Kwon BS, Cho HS: Crystallization and preliminary X-ray crystallographic study of the extracellular domain of the 4-1BB ligand, a member of the TNF family. Acta Cryst 62(Pt1):23-25, 2006

195. Choi BK, Tatsuhiko Asai, Vinay DS, Kim YH, Kwon BS: 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2, 3-dioxygenase-dependent mechanisms. Cytokine 34:233-242, 2006

196. Lee SK, Choi BK, Kim YH, Kang WJ, Kim KH, Sakaguchi S, Kim TY, Kwon BS: Glucocorticoid-       induced TNFR family-related receptor exacerbates hapten-induced colitis by CD4+ T cells. Immunology 119:479-487, 2006

197. Vinay DS,Cha K, Kwon BS: Dual immunoregulatory pathways of 4-1BB signaling. J Mol Med 84:726-736, 2006

198. Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R: Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond) 30:1347-1355, 2006

199. Vinay DS, Kim JD, Kwon BS: Amelioration of mercury-induced prototypic Th2 autoimmunity by 4-1BB. J Immunol 177:5708-5717, 2006

200. Kim WJ, Bae EM, Kang YJ, Bae HU, Hong SH, Lee JY, Park JE, Kwon BS, Suk K, Lee WH: Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 119:421-429, 2006

201. Shin HH, Lee JE, Lee EA, Kwon BS, Choi HS: Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10. J Bone Miner Res 21:1907-1912, 2006

202. Haselmayer P, Tenzer S, Kwon BS, Jung G, Schild H, Radsak MP: Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses. Immunology 119:404-411, 2006

203. Yu R, Kim CS, Kwon BS, Kawada T: Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity (Silver Spring) 14:1353-1362, 2006

204. Lee SW, Park Y, Song A, Cheroutre H, Kwon BS, Croft M: Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses. J Immunol 177:4464-4472, 2006

205. Lee MY, Kim WJ, Kang YJ, Jung YM, Kang YM, Suk K, Park JE, Choi EM, Choi BK, Kwon BS, Lee WH: Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J Leukoc Biol 80:922-928, 2006

206. Lee EA, Kim JE, Seo JH, Kwon BS, Nam SH, Kwon B, Cho HR: 4-1BB (CD137) signals depend upon CD28 signals in alloimmune responses. Exp Mol Med 38:606-615, 2006 

207. Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, Archer D, Spencer T, Dillehay D, Kwon BS, Chen L, Vella AT, Mittler RS: Cytokine-mediated disruption of lymphocyte trafficking, hematopoiesis, induction of lymphopenia, anemia, thrombocytopenia in anti-CD137 treated mice. J Immunol 178:4194-4213, 2007

208. Shin YH, Lee GW, Son KN, Lee SM, Kang CJ, Kwon BS, Kim J:  Promoter analysis of human CC chemokine CCL23 gene in U937 monocytoid cells. Biochim Biophys Acta 1769:204-208, 2007

209. Asai T, Choi BK, Kwon PM, Kim WY, Kim JD, Vinay DS, Gebhardt BM, Kwon BS: Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice. Immunology 121:349-358, 2007.

210. Shin SM, Kim YH, Choi BK, Kwon PM, Lee HW, Kwon BS: 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation. J Leukoc Biol 81:1455-1465, 2007

211. Kang YJ, Kim SO, Shimada S, Otsuka M, Seit-Nebi A, Kwon BS, Watts TH, Han J: Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nature Immunol 8:601-609, 2007

212. Bae EM, Kim WJ, Suk K, Kang YM, Park JE, Kim WY, Choi EM, Choi BK, Kwon BS, Lee WH: Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol Immunol 45:523-533, 2007

213. Vinay DS, Choi JH, Kim JD, Choi BK, Kwon BS: Role of endogenous 4-1BB in the development of systemic lupus erythematosus. Immunology 122:394-400, 2007

214. Rudolf D, Silberzahn T, Walter S, Maurer D, Engelhard J, Wernet D, Buhring HJ, Jung G, Kwon BS, Rammensee HG, Stevanovic S: Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells. Cancer Immunol Immunother 57:175-183, 2007

215. Lee SJ, Rossi RJ, Lee SK, Croft M, Kwon BS, Mittler RS, Vella AT: CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent. J Immunol 179:2203-2214, 2007

216. Ju SA, Park SM, Lee SC, Kwon BS, Kim BS: Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody. Mol Cells 24:132-138, 2007

217. Zhang B, Maris CH, Foell J, Whitmire J, Niu L, Song J, Kwon BS, Vella AT, Ahmed R, Jacob J, Mittler RS: Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. J Clin Invest 117:3029-3041, 2007

218. Choi BK, Kim YH, Kang WJ, Lee SK, Kim KH, Shin SM, Yokoyama WM, Kim TY, Kwon BS: Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy. Cancer Res 67:8891-8899, 2007

219. Vinay DS, Kim JD, Asai T, Choi BK, Kwon BS: Absence of 4-1BB Gene Function Exacerbates Lacrimal Gland Inflammation in Autoimmune-Prone MRL-Faslpr Mice. Invest Ophthalmol Vis Sci 48:4608-4615, 2007

220. Kim YS, Jung HW, Choi J, Kwon BS, Ham SY, Jung AK, Ko BK: Expression of AITR and AITR ligand in breast cancer patients. Oncol Rep 18:1189-1194, 2007

221. Heo SK, Yoon MA, Lee SC, Ju SA, Choi JH, Suh PG, Kwon BS, Kim BS: HVEM signaling in monocytes is mediated by intracellular calcium mobilization. J Immunol 179:6305-6310, 2007

222. Park MS, Lee HM, Hahn SB, Moon SH, Kim YT, Lee CS, Jung HW, Kwon BS, Riew KD: The association of the activation-inducible tumor necrosis factor receptor and ligand with lumbar disc herniation. Yonsei Med J 48:839-846, 2007

223. Sul OJ, Lee HW, Kim WK, Choi JH, Kwak JS, Choi YJ, Latour AM, Koller BH, Jeong CS, Kwon BS: Regulation of the murine TR2/HVEM gene expression by IRF. Biochem Biophys Res Commun.  367:277-83, 2008

224. Kim DH, Chang WS, Lee YS, Lee KA, Kim YK, Kwon BS, Kang CY: 4-1BB Engagement Costimulates NKT Cell Activation and Exacerbates NKT Cell Ligand-Induced Airway Hyperresponsiveness and Inflammation. J Immunol 180:2062-2068, 2008

225. Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kawada T, Kwon BS, Yu R: Visceral Fat Accumulation Induced by a High-fat Diet Causes the Atrophy of Mesenteric Lymph Nodes in Obese Mice. Obesity (Silver Spring). 16:1261-1269, 2008

226. Kim WJ, Kang YJ, Suk K, Park JE, Kwon BS, Lee WH: Comparative analysis of the expression patterns of various TNFSF/TNFRSF in atherosclerotic plaques. Immunol Invest  37:359-73, 2008

227. Lee SK, Choi BK, Kang WJ, Kim YH, Park HY, Kim KH, Kwon BS: MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis  Mol Cells  26:67-73, 2008

228. Lee SW, Park Y, So T, Kwon BS, Cheroutre H, Mittler RS, Croft M: Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nature Immunol 9:917-926, 2008

229. Kim YH, Choi BK, Kim Kh, Kang SW, Kwon BS: Combination therapy with cisplatin and anti-4-1BB; Synergistic anti-cancer effects and amelioration of cisplatin-induced nephrotoxicity. Cancer Res 68:7264-7269, 2008

230. Choi BK, Kim YH, Choi EM, Lee SK, Lee SC, Kang SW, Song KM, Kim MS, Lee MJ, Ngo VG, Kwon BS: 4-1BB functions as a survival factor in dendritic cells. J Immunol 182:4107-4115, 2009

231. Kim YH, Choi BK, Oh HS, Kang WJ, Mittler RS, Kwon BS: Mechanisms involved in synergistic anti-cancer effects of anti-4-1BB and cyclophosphamide therapy. Mol Cancer Ther 8:469-478, 2009

232. Kim YH, Choi BK, Kang WJ, Kim KH, Kang SW, Mellor AL, Munn DH, Kwon BS: IFN-gamma-indoleamine 2, 3-dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo. J. Leukoc Biol  85:817-825, 2009

233. Vinay DS, Kwon BS: TNF Superfamily: Costimulation and clinical application. Cell Biol Int 33:453-465, 2009

234. Choi JH, Ryu YS, Kim KH, Cha KW, Han IS, Kwon BS: In vitro development of a hemangioblast from a human embryonic stem cell, SNUhES#3. Life Sci 3:39-45, 2009

235. Vinay DS, Kim CH, Choi BK, Kwon BS: Origins and functional basis of regulatory CD11c+CD8+ T cells. Eur J Immunol 39:1552-1563, 2009

236. Kim YM, Kin HK, Kim HJ, Lee HW, Ju SA, Choi BK, Kwon BS, Kim BS, Kim JB, Lim YT, Yoon S: Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration. Exp Mol Med 41:896-911, 2009

237. Jeon ST, Kim WJ, Lee SM, Lee MY, Park SB, Lee SH, Kim IS, Suk K, Choi BK, Choi EM, Kwon BS, Lee WH: Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol Cell Biol  88:148-156, 2010

238. Vinay DS, Kim CH, Chang KH, Kwon BS: PDCA expression by B lymphocytes reveals important functional attributes. J Immunol 184:807-815, 2010

239. Won EY, Cha K, Byun JS, Kim DU, Shin S, Ahn B, Kim YH, Rice AJ, Walz T, Kwon BS, Cho HS: The structure of the trimer of human 4-1BB ligand is unique among members of the TNF superfamily. J Biol Chem  285:9202-9210, 2010

240. JeonHJ, Choi JH, Jung IH, Park JG, Lee MR, Lee MN, Kim B, Yoo JY, Jeong SJ, Kim DY, Park JE, Park HY, Kwack K, Choi BK, Kwon BS, Oh GT: CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation. 121:1124-1133,  2010

241. Dass SV, Kwon BS: CD11c+ CD8+  T cells: Two-faced Adaptive  Immune Regulators. Cell Immunol  264:18-22, 2010

242. Lin GHY, Liu Y, Ambagala T, Kwon BS, Ohashi PS, Watts TH: Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice. PLOS ONE 5:e11003, 2010

243. Choi BK, Kim YH, Kim CH, Kim MS, Kim KH, Oh HS, Lee MJ, Lee DK, Vinay DS, Kwon BS: Peripheral 4-1BB signaling negatively regulates natural killer cell development through IFN-Manipulation of the immune system represents a promising avenue for cancer therapy. Rational advances g. J Immunol  185:1404-11, 2010

244. Hsieh EH, Fernandez X, Wang J, Hamer MS, Calvillo S, Croft M, Kwon BS, Lo DD: CD137 is required for M cell functional maturation but not lineage commitment. Am J Pathol 177:666-76, 2010

245. Kim JD, Kim CH, Kwon BS: Regulation of mouse 4-1BB expression: Multiple promoter usages and a splice variant. Mol Cells 31:141-9, 2011

246. Kim WK, Park JS, Sul OJ, Seo JH, Choi BK, Park HY, Latour AM, Koller BH, Kwon BS, Jeong CS: Role of TNFR-related 2 mediated immune responses in dextran sulfate sodium-induced inflammatory bowel disease. Mol Cells 31:99-104, 2011

247. Vinay DS, Kwon BS: 4-1BB signaling beyond T cells. Cell Mol Immunol 8:281-284, 2011

248. Vinay DS, Kwon BS: The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases. Clin Exp Immunol 164: 145-157, 2011

249. Choi BK, Kim YH, Choi JH, Kim CH, Kim KS, Sung YC, Lee YM, Moffett JR, Kwon BS: Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo. Cytokine 55:420-8, 2011

250. Kim YH, Choi BK, Shin SM, Kim CH, Oh HS, Park SH, Lee DG, Lee MJ, Kim KH, Vinay DS, Kwon BS: 4-1BB Triggering Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Balance between Th17 and Regulatory T Cells. J Immunol 187:1120-8, 2011

251. Lee DG, Lee JH, Choi BK, Kim MJ, Kim SM, Kim KS, Chang K, Park SH, Bae YS, Kwon BS: H(+)-Myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma. Curr Cancer Drug Targets 11:966-975, 2011

252. Kim HJ, Lee JS, Kim JD, Cha HJ, Kim A, Lee SK, Lee SC, Kwon BS, Mittler RS, Cho HR, Kwon B.: Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc Natl Acad Sci USA 109:13-22, 2012

253. Vinay DS, Kwon BS: Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine 57: 305-312, 2012

254. Vinay DS, Kwon BS: Immunotherapy of Cancer with 4-1BB. Mol Cancer Ther 11:1062-1070, 2012

255. Kwon BS, Ha CM, Yu S, Lee BC, Ro JY, Hwang S. : Microscopic nodes and ducts inside lymphatics and on the surface of internal organs are rich in granulocytes and secretory granules. Cytokine 60 (2) : 587-92 , 2012

256. Kim KH, Choi BK, Kim JD, Kim YH, Lee SK, Suh JH, Lee SC, Kang SW, Kwon BS: 4-1BB Signaling Breaks the Tolerance of Maternal CD8(+) T Cells That Are Reactive with Alloantigens. PLoS One 7(9) : e45481, 2012

257. Vinay DS, Lee SJ, Kim CH, Oh HS, Kwon BS : Exposure of a Distinct PDCA-1(+) (CD317) B Cell Population to Agonistic Anti-4-1BB (CD137) Inhibits T and B Cell Responses Both In Vitro and In Vivo. PLoS One 7(11) : e50272, 2012

258. Vinay DS, Kwon BS.: Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine 57(3):305-12, 2012

259. Kim KH, Choi BK, Song KM, Cha KW, Kim YH, Lee H, Han IS, Kwon BS. : CRIg signals induce anti-intracellular bacterial phagosome activity in a chloride intracellular channel 3-dependent manner. Eur J Immunol 43(3) : 667-78, 2013

260. Nguyen QT, Nguyen TH, Ju SA, Lee YS, Han SH, Lee SC, Kwon BS, Yu R, Kim GY, Lee BJ, Kim BS. : CD137 expressed on neutrophils plays dual roles in antibacterial responses against Gram-positive and Gram-negative bacterial infections. Infect Immun 81(6):2168-77, 2013

261. Lee SJ, Kim YH, Hwang SH, Kim YI, Han IS, Vinay DS, Kwon BS.: 4-1BB signal stimulates the activation, expansion, and effector functions of γδ T cells in mice and humans. Eur J Immunol 43(7):1839-48, 2013

262. Lee DY, Choi BK, Lee DG, Kim YH, Kim CH, Lee SJ, Kwon BS : 4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8(+) T Cells. PLoS One 8(7):69677, 2013

263. Kim HJ, Lee JS, Kim A, Koo S, Cha HJ, Han JA, Do Y, Kim KM, Kwon BS, Mittler RS, Cho HR, Kwon B.: TLR2 Signaling in Tubular Epithelial Cells Regulates NK Cell Recruitment in Kidney Ischemia-Reperfusion Injury. J Immunol 191(5):2657-64, 2013

264. Vinay DS, Kwon BS: 4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy. BMB 47(3):122-9, 2014

265. Choi BK, Lee SC, Lee MJ, Kim YH, Kim YW, Ryu KW, Lee JH, Shin SM, Lee SH, Suzuki S, Oh HS, Kim CH, Lee DG, Hwang SH, Yu EM, Lee IO, Kwon BS : 4-1BB-based isolation and expansion of CD8+ T cells specific for self-tumor and non-self-tumor antigens for adoptive T-cell therapy. J Immunother 37(4):225-36, 2014

266. Hwang S, Lee SJ, Park SH, Chitteti BR, Srour EF, Cooper S, Hangoc G, Broxmeyer HE, Kwon BS: Non-marrow hematopoiesis occurs in a hyaluronic acid-rich node and duct system in mice. Stem Cells Dev 23(21):2661-71, 2014

267. Lee SJ, Park SH, Kim YI, Hwang S, Kwon PM, Han IS, Kwon BS: Adult stem cells from the hyaluronic Acid-rich node and duct system differentiate into neuronal cells and repair brain injury. Stem Cells Dev 23(23):2831-40, 2014

268. Jung IH, Choi JH, Jin J, Jeong SJ, Jeon S, Lim C, Lee MR, Yoo JY, Sonn SK, Kim YH, Choi BK, Kwon BS, Seoh JY, Lee CW, Kim DY, Oh GT : CD137-inducing factors from T cells and macrophages accelerate the destabilization of atherosclerotic plaques in hyperlipidemic mice. FASEB J. 28(11):4779-91, 2014

269. Lee SC, Seo KW, Kim HJ, Kang SW, Choi HJ, Kim A, Kwon BS, Cho HR, Kwon B: Depletion of alloreactive T cells by anti-CD137-saporin immunotoxin. Cell Transplant. 2014 Mar 3. [in press]

270. Park JW, Park DM, Choi BK, Kwon BS, Seong JK, Green JE, Kim DY, Kim HK: Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E-cadherin. Mol Carcinog. 2014 Oct 12. doi: 10.1002/mc.22226.

271. Choi BK, Kim YH, Lee DG, Oh HS, Kim KH, Park SH, Lee J, Vinay DS, Kwon BS: In vivo 4-1BB deficiency in myeloid cells enhances peripheral T cell proliferation by increasing IL-15. J Immunol. 194(4):1580-90, 2015

272. Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HM, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS: Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 35 Suppl: S185-98, 2015.

273. Oh HS, Choi BK, Kim YH, Lee DG, Hwang S, Lee MJ, Park SH, Bae YS, Kwon BS: 4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling. PLoS One.10(5):e0126765, 2015

274. Rai R, Chandra V, Kwon BS. : A hyaluronic acid-rich Node and Duct System in which plurpotent adult stem cells circulate. Stem Cells Dev. 24: 2243-58, 2015

275. Kim IK, Kim BS, Koh CH, Seok JW, Park JS, Shin KS, Bae EA, Lee GE, Jeon H, Cho J, Jung Y, Han D, Kwon BS, Lee HY, Chung Y, Kang CY. : Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9 producing helper T cells. Nat Med. 21: 1010-7, 2015

276. Kim YH, Shin SM, Choi BK, Oh HS, Kim CH, Lee SJ, Kim KH, Lee DG, Park SH, Kwon BS: Authentic GITR signaling fails to induce tumor regression unless Foxp3+ regulatory T cells are depleted. J Immunol. 195: 4721-9, 2015  

277. Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AM, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HP, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HM, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M. : Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 35 Suppl:S276-304, 2015 Review.

278. Kim YH, Shin SM, Choi BK, Oh HS, Kim CH, Lee SJ, Kim KH, Lee DG, Park SH, Kwon BS: Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted. J Immunol.195(10):4721-9, 2015  

279. Vinay DS, Kwon BS: Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies. Expert Opin Ther Targets.20(3):361-73, 2016

280. Choi BK, Lee DY, Lee DG, Kim YH, Kim SH, Oh HS, Han C, Kwon BS: 4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation. Cell Mol Immunol. 2016 Mar 14. doi: 10.1038/cmi.2016.02

281. Eom HS, Choi BK, Lee Y, Lee H, Yun T, Kim YH, Lee JJ, Kwon BS: Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors. J Immunother. 39(3):140-8, 2016

282. Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Semeraro M, Jégou S, Flores C, Chen L, Kwon BS, Borg C, Weide B, Aubin F, Dalle S, Kohrt H, Ayyoub M, Kroemer G, Marabelle A, Cavalcanti A, Eggermont A, Zitvogel L: Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis. J Invest Dermatol.136(5):994-1001, 2016

283. Kim KH, Choi BK, Kim YH, Han Chungyong, Oh HS, Lee DG, Kwon BS: Extracellular stimulation of complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy. Autophagy. 12:1647-1659, 2016

284. Lee DG, Choi BK, Kim YH, Oh HS, Park SH, Bae YS, Kwon BS: The repopulating cancer cells in melanoma are characterized by increased mitochondrial membrane potential. Cancer Letters, 382:186-194, 2016

Register Now



Highlights

Brochure

Get Your Free Immune Sandiego 2018 ,San Diego Conference Brochure